Detalhe da pesquisa
1.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086745
2.
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Clin Transl Oncol
; 25(9): 2647-2664, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326826
3.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230628
4.
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Breast
; 66: 77-84, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206609
5.
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Clin Transl Oncol
; 26(2): 555-556, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902930
6.
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
J Drug Assess
; 8(1): 62-69, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069129
7.
[Euthanasia in patients with cancer and the continuous-care providers]. / La eutanasia en el paciente con cáncer y los cuidados continuos.
Clin Transl Oncol
; 7(7): 278-84, 2005 Aug.
Artigo
em Espanhol
| MEDLINE | ID: mdl-16185589
8.
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Clin Transl Oncol
; 11(11): 727-36, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917536